Intelligent Production Systems for Cell Therapy
Intelligent Production Systems for Cell Therapy
Intelligent Production Systems for Cell Therapy
OUR GENESIS
OUR GENESIS
Celleo originated at the intersection of great biology and great engineering. Sparks fly at the intersection.
Our mission is to enable Cell & Gene Therapies to deliver population-level health outcomes, realizing the extraordinary potential of humanity’s most powerful therapeutic modality – our cells, augmented.
We contribute intelligent production systems for the manufacture of Cell & Gene Therapies.
Our 3 co-founders each bring nearly 20 years of deep industry experience in the development and production of Cell & Gene Therapies. Celleo develops GMP production systems in collaboration with leading commercial biotherapeutics players, developers of novel therapeutics at pre-clinical to clinical stage, CDMOs, and major university medical centers.
Our production systems seek to accommodate, not dictate, the diversity of processes, modalities and business models characteristic of our vibrant industry.
Steve Jobs predicted “…the biggest innovations of the 21st century will be at the intersection of biology and technology.” Today’s Cell & Gene Therapy industry is approaching a tipping point – from a limited set of therapeutics changing the lives of a fortunate few, to a broadly available toolkit for physicians providing a new standard of personalized care. We’re here to hasten that transition.
Millions of patients in need deserve it.
Thousands of Cell Therapy professionals deserve it too.
MEET THE FOUNDERS
MEET THE FOUNDERS
NEWS
NEWS
Ministerial visit recognises facility manufacturing Celleo consumables
Hon. Colin Brooks visiting Celleo’s production line for Cell Therapy consumables at Forme (during cleanroom shut-down!) Left to right: Michael Papadopolous, QA Manager, Forme | Matthew Stewart, Production Manager, Forme | Mirko Tappero, GM, Forme | Hon. Colin Brooks, Victorian Minister for Industry and Advanced Manufacturing | David Kneen, CEO, Celleo | Robert Anderson, MD, Forme | Heidi Bergman, PM, Celleo | Jonathan Reichwald, Regional Director S&E Metro, Invest Victoria Thursday, 9th April 2026 The Hon. Colin Brooks, Victorian Minister for Industry and Advanced Manufacturing, today visited medical plastics specialist Forme Technologies, accompanied by Celleo CEO David Kneen, inspecting the cleanroom facility producing Celleo’s core consumables. The world’s leading cell and gene therapy manufacturers rely on Celleo’s products to deliver life-saving therapies to patients – a strong Victorian ecosystem for Advanced Manufacturing is fundamental to ensuring Celleo’s supply chain remains robust. The Minister’s visit emphasised the strength of Victoria’s Advanced Manufacturing capabilities, exemplified by Celleo’s production line. Celleo’s core consumables are manufactured through an advanced series of automated operations, within a world-class ISO7 cleanroom commissioned by Forme to meet Celleo’s requirements. “Victoria continues to demonstrate world-class capability in Advanced Manufacturing,” said Minister Brooks. “We’re proud to back partnerships such as this, where cutting-edge infrastructure and highly-skilled teams come together to produce high-quality products with global impact. Forme Technologies and Celleo are exemplars of Victorian innovation – delivering essential medical products worldwide.” “Our [...]
